Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Year-over-year SG&A expense growth
3Y CAGR
-48.5%/yr
vs +94.3%/yr prior
Acceleration
-142.8pp
Decelerating
Percentile
P71
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 25.31% |
| 2024 | 3.45% |
| 2023 | 3.94% |
| 2022 | 185.21% |
| 2021 | 10.03% |
| 2020 | -40.80% |
| 2019 | 27.05% |
| 2018 | 12.98% |
| 2017 | 17.37% |
| 2016 | 14.55% |